Download
Download by
Scanning QR Code
Download app
Download app
Company Overview More
Xianjian Technology Co., Ltd. is a minimally invasive interventional medical device business mainly engaged in manufacturing and marketing minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through three business divisions. The congenital Heart Disease Business Division is engaged in the research, development, manufacture and trading of equipment related to the treatment of congenital and structural heart disease. The peripheral vascular disease business division is engaged in the research, development, manufacture and trading of equipment related to the treatment of peripheral vascular diseases. The surgical vascular repair business division is engaged in the research, development, manufacture and trading of equipment related to surgical vascular repair.
CEO: Yuehui Xie
Market: Hong Kong motherboard
Futu Hot List
HKUSCN
Trade HeatSearch HeatNews Heat
SymbolLatest price%Chg

Loading...

Watchlist
Futubull > Quotes > 01302 LIFETECH SCI > Key Indicators
01302 LIFETECH SCI
3.120-0.060-1.89%
YOY
Do not show
Hide blank lines
(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30(FY)2019/12/31
Per Share IndicaTor
Operating Cash Flow Per Share
92.78% 0.0518 22.34% 0.0869 -9.81% 0.0269 47.75% 0.0711
Cash Flow Per Share
-1671.73% -0.0998 1345.85% 0.1725 130.5% 0.0063 47.28% -0.0138
Operating Income Per Share
73.37% 0.1198 -4.58% 0.1649 -14.72% 0.0691 17.69% 0.1728
Net Asset Per Share
107.58% 0.6633 101.86% 0.6009 -10.69% 0.3196 -9.03% 0.2977
Basic Earning Per Share
124% 0.056 68.57% 0.059 4.17% 0.025 9.38% 0.035
Diluted  Earning Per Share
116% 0.054 65.71% 0.058 4.17% 0.025 9.38% 0.035
Profitability
Gross Profit Ratio
2.08% 81.180% -0.08% 79.892% -3.29% 79.524% -2.18% 79.958%
Operating Profit Ratio
12.51% 49.363% 45.92% 41.178% 18.88% 43.875% -4.32% 28.220%
Net Profit Ratio
23.48% 43.512% 69.55% 32.235% 17.51% 35.238% -12.79% 19.012%
Earning Before Tax Ratio
23.07% 50.271% 47.92% 37.774% 15.86% 40.847% -14.97% 25.537%
ROE
3.44% 8.398% 18.41% 12.627% 14.76% 8.119% 3.31% 10.664%
ROA
26.92% 6.795% 20.97% 9.355% 1.43% 5.354% -8.51% 7.734%
Yield Quality
Operating Profit To Total Profits
-8.58% 98.193% -1.35% 109.012% 2.61% 107.413% 12.52% 110.505%
Tax To Total Profits
-2.09% 13.446% -42.61% 14.665% -8.08% 13.733% -6.79% 25.553%
Operating Cash To Total Revenue
11.19% 43.228% 28.2% 52.706% 5.76% 38.878% 25.54% 41.111%
Capital Structure
Debt Assets Ratio
-48.61% 16.851% -41.44% 20.174% 8.44% 32.789% 83.64% 34.452%
Equity Multipler
-19% 1.2118 -17.93% 1.2626 4.09% 1.496 24.63% 1.5384
Debt Equity Ratio
-58.46% 20.266% -51.92% 25.273% 12.56% 48.786% 127.61% 52.560%
Current Assets To tatal Assets
55.7% 51.807% 52.96% 52.287% -1.6% 33.275% -9.45% 34.183%
Non Current Assets To Total Assets
-27.77% 48.193% -27.51% 47.713% 0.82% 66.725% 5.73% 65.817%
Current Liabilities To tatal Liabilities
3.62% 79.446% 48.18% 82.811% 48.41% 76.667% -22.92% 55.887%
Non Current Liabilities To Total Liabilities
-11.91% 20.554% -61.03% 17.189% -51.73% 23.333% 60.45% 44.113%
Solvency
Current Ratio
192.36% 3.8698 76.29% 3.1297 -38.86% 1.3236 -36.03% 1.7754
Quick Ratio
220.28% 3.6167 97.18% 2.9279 -38.92% 1.1292 -39.03% 1.4849
Operating Profit To Current Liabilities
117.83% 0.5493 -3.13% 0.5358 -32.24% 0.2522 -29.83% 0.5532
Operrating Cash Flow To Current Liabilities
115.28% 0.4811 -14.9% 0.6858 -39.72% 0.2235 -7.93% 0.8059
Share Equity Without Minority Interest To Total Liabilities
140.21% 4.8971 108.08% 3.926 -11.41% 2.0387 -56.31% 1.8868
Operating Cash Flow To Total Liabilities
123.08% 0.3822 26.1% 0.568 -10.54% 0.1713 -29.04% 0.4504
Operating Profit To Total Liabilities
125.73% 0.4364 43.53% 0.4437 0.57% 0.1933 -45.92% 0.3091
Operating Capacity
Inventory Turnover(T)
47.69% 0.8536 -14.23% 1.3401 -11.49% 0.578 -13.86% 1.5624
Current Assets Turnover(T)
-32.75% 0.2946 -45.58% 0.6077 -11.68% 0.438 21.88% 1.1166
Fixed Assets Turnover(T)
39% 1.0119 -8.44% 1.6936 -17.07% 0.728 14.18% 1.8497
Total Assets Turnover(T)
3.8% 0.1533 -30.55% 0.2781 -16.22% 0.1477 3.02% 0.4004
Growth Ability
Operating Revenue GR 3Y
88.14% 89.260% -38.32% 55.253% -48.32% 47.444% 25.78% 89.582%
Gross Income GR 3Y
85.25% 85.729% -43.41% 52.868% -53.22% 46.279% 28.58% 93.418%
Operating Profit GR 3Y
490.3% 146.590% -51.44% 36.081% -72.55% 24.833% 11.56% 74.297%
EBT GR 3Y
891.3% 144.715% 377.33% 23.918% -78.3% 14.598% -101.7% -8.625%
Net Profit GR 3Y
2254.1% 201.359% 297.88% 25.171% -88.3% 8.554% -100.46% -12.720%
Net Profit Attributable To The Parent Company GR 3Y
1681.13% 207.612% 372.15% 30.719% -84.03% 11.656% -100.23% -11.287%
Total Assets GR 3Y
318.27% 133.400% 291.24% 130.107% -66.49% 31.893% -59.93% 33.255%
Share Equity Without Minority Interest GR 3Y
411.02% 125.364% 265.41% 119.819% -94.36% 24.532% -94.14% 32.791%
Equity GR 3Y
409.19% 126.418% 261.41% 120.873% -94.24% 24.827% -94.04% 33.445%
Total Liabilities GR 3Y
256.24% 175.287% 434.16% 175.714% 338.24% 49.205% 159.04% 32.895%
Basic Earning Per Share GR 3Y
1328.07% 194.737% 326.09% 28.261% -77.27% 13.636% -100.4% -12.500%
Net Assets Per Share GR 3Y
354.13% 111.168% 222.07% 105.685% -93.8% 24.480% -93.55% 32.815%
Other Indicators
Currency Unit
HKDHKDHKDHKD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Back to the Top